Europe — EMA

Oxaliplatinum Accord

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatin Accord, is a platinum-based antineoplastic agent presented as a injection for intravenous use. It treats colorectal cancer and other solid tumours in adult patients. GNH USA supplies Oxaliplatin Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Oxaliplatin Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and oncology centres worldwide.

What is Oxaliplatin used for?

Oxaliplatin Accord is a platinum‑based chemotherapy that acts on rapidly ....

- Colorectal cancer: It ... etc… ... ... ... ... ... ... .... - ... .... ..... - .... .... ...

What are the side effects of Oxaliplatin?

This … .... ... … ... … ... ... .... ... ... … … …

What precautions apply to Oxaliplatin?

...

What does Oxaliplatin interact with?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →